BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20177122)

  • 1. Responsiveness of different rating instruments in spinocerebellar ataxia patients.
    Schmitz-Hübsch T; Fimmers R; Rakowicz M; Rola R; Zdzienicka E; Fancellu R; Mariotti C; Linnemann C; Schöls L; Timmann D; Filla A; Salvatore E; Infante J; Giunti P; Labrum R; Kremer B; van de Warrenburg BP; Baliko L; Melegh B; Depondt C; Schulz J; du Montcel ST; Klockgether T
    Neurology; 2010 Feb; 74(8):678-84. PubMed ID: 20177122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment.
    du Montcel ST; Charles P; Ribai P; Goizet C; Le Bayon A; Labauge P; Guyant-Maréchal L; Forlani S; Jauffret C; Vandenberghe N; N'guyen K; Le Ber I; Devos D; Vincitorio CM; Manto MU; Tison F; Hannequin D; Ruberg M; Brice A; Durr A
    Brain; 2008 May; 131(Pt 5):1352-61. PubMed ID: 18378516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia.
    Schmitz-Hübsch T; Giunti P; Stephenson DA; Globas C; Baliko L; Saccà F; Mariotti C; Rakowicz M; Szymanski S; Infante J; van de Warrenburg BP; Timmann D; Fancellu R; Rola R; Depondt C; Schöls L; Zdzienicka E; Kang JS; Döhlinger S; Kremer B; Melegh B; Filla A; Klockgether T
    Neurology; 2008 Aug; 71(7):486-92. PubMed ID: 18695159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-rated health status in spinocerebellar ataxia--results from a European multicenter study.
    Schmitz-Hübsch T; Coudert M; Giunti P; Globas C; Baliko L; Fancellu R; Mariotti C; Filla A; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Rola R; Depondt C; Schöls L; Zdzienicka E; Kang JS; Ratzka S; Kremer B; Schulz JB; Klopstock T; Melegh B; du Montcel ST; Klockgether T
    Mov Disord; 2010 Apr; 25(5):587-95. PubMed ID: 20175183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
    J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scale for the assessment and rating of ataxia: development of a new clinical scale.
    Schmitz-Hübsch T; du Montcel ST; Baliko L; Berciano J; Boesch S; Depondt C; Giunti P; Globas C; Infante J; Kang JS; Kremer B; Mariotti C; Melegh B; Pandolfo M; Rakowicz M; Ribai P; Rola R; Schöls L; Szymanski S; van de Warrenburg BP; Dürr A; Klockgether T; Fancellu R
    Neurology; 2006 Jun; 66(11):1717-20. PubMed ID: 16769946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2.
    Monte TL; Reckziegel ER; Augustin MC; Silva ASP; Locks-Coelho LD; Barsottini O; Pedroso JL; Vargas FR; Saraiva-Pereira ML; Leotti VB; Jardim LB;
    Cerebellum; 2017 Aug; 16(4):852-858. PubMed ID: 28456900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression of spinocerebellar ataxia types 1, 2, 3 and 6 before and after ataxia onset.
    Jacobi H; Schaprian T; Schmitz-Hübsch T; Schmid M; Klockgether T;
    Ann Clin Transl Neurol; 2023 Oct; 10(10):1833-1843. PubMed ID: 37592453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of the scale for the assessment and rating of ataxia: a study in 64 ataxia patients.
    Weyer A; Abele M; Schmitz-Hübsch T; Schoch B; Frings M; Timmann D; Klockgether T
    Mov Disord; 2007 Aug; 22(11):1633-7. PubMed ID: 17516493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.
    Diallo A; Jacobi H; Cook A; Labrum R; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sobanska A; Sulek A; Schmitz-Hübsch T; Schöls L; Hengel H; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Boesch S; Pandolfo M; Schulz JB; Bauer P; Giunti P; Kang JS; Klockgether T; Tezenas du Montcel S
    Lancet Neurol; 2018 Apr; 17(4):327-334. PubMed ID: 29553382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients.
    Schmitz-Hübsch T; Tezenas du Montcel S; Baliko L; Boesch S; Bonato S; Fancellu R; Giunti P; Globas C; Kang JS; Kremer B; Mariotti C; Melegh B; Rakowicz M; Rola R; Romano S; Schöls L; Szymanski S; van de Warrenburg BP; Zdzienicka E; Dürr A; Klockgether T
    Mov Disord; 2006 May; 21(5):699-704. PubMed ID: 16450347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.
    Reetz K; Dogan I; Hilgers RD; Giunti P; Mariotti C; Durr A; Boesch S; Klopstock T; de Rivera FJR; Schöls L; Klockgether T; Bürk K; Rai M; Pandolfo M; Schulz JB;
    Lancet Neurol; 2016 Dec; 15(13):1346-1354. PubMed ID: 27839651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.
    Jacobi H; Bauer P; Giunti P; Labrum R; Sweeney MG; Charles P; Dürr A; Marelli C; Globas C; Linnemann C; Schöls L; Rakowicz M; Rola R; Zdzienicka E; Schmitz-Hübsch T; Fancellu R; Mariotti C; Tomasello C; Baliko L; Melegh B; Filla A; Rinaldi C; van de Warrenburg BP; Verstappen CC; Szymanski S; Berciano J; Infante J; Timmann D; Boesch S; Hering S; Depondt C; Pandolfo M; Kang JS; Ratzka S; Schulz J; Tezenas du Montcel S; Klockgether T
    Neurology; 2011 Sep; 77(11):1035-41. PubMed ID: 21832228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validating an Ataxia Functional Composite Scale in spinocerebellar ataxia.
    Assadi M; Leone P; Veloski JJ; Schwartzman RJ; Janson CG; Campellone JV
    J Neurol Sci; 2008 May; 268(1-2):136-9. PubMed ID: 18191149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social economic costs and health-related quality of life in patients with degenerative cerebellar ataxia in Spain.
    López-Bastida J; Perestelo-Pérez L; Montón-Alvarez F; Serrano-Aguilar P
    Mov Disord; 2008 Jan; 23(2):212-7. PubMed ID: 17999424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reliability of the Japanese version of the Scale for the Assessment and Rating of Ataxia (SARA)].
    Sato K; Yabe I; Soma H; Yasui K; Ito M; Shimohata T; Onodera O; Nakashima K; Sobue G; Nishizawa M; Sasaki H
    Brain Nerve; 2009 May; 61(5):591-5. PubMed ID: 19514520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.